Author:
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2
Book Description
Coronary Primary Prevention Trial
Author:
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2
Book Description
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2
Book Description
Treatment of Hyperlipoproteinemia
Author: Anders G. Olsson
Publisher: Raven Press (ID)
ISBN:
Category : Arteriosclerosis
Languages : en
Pages : 312
Book Description
Publisher: Raven Press (ID)
ISBN:
Category : Arteriosclerosis
Languages : en
Pages : 312
Book Description
Hyperlipidemia
Author: Basil M. Rifkind
Publisher: Saunders
ISBN:
Category : Medical
Languages : en
Pages : 424
Book Description
Abstract: The diagnosis and management of hyperlipidemic and hyperlipoproteinemic states are explored from various points of view. Epidemiological observations show an inverse relationship between high density lipoprotein levels and coronary heart disease. Biochemical findings indicate how lipoproteins interact and exert their physiological and pathophysiological effects. Lipids and lipoproteins, in general are discussed. The plasma cholesteral health consequences involve lipid distribution. Research, review and evolution of clinical trials of lipid lowering to prevent coronary heart disease are included. Specific topics include various aspects of hyperlipoproteinemia: classification, diagnosis, primary and secondary types, genetic characteristics, dietary and drug treatment, and surgical management.
Publisher: Saunders
ISBN:
Category : Medical
Languages : en
Pages : 424
Book Description
Abstract: The diagnosis and management of hyperlipidemic and hyperlipoproteinemic states are explored from various points of view. Epidemiological observations show an inverse relationship between high density lipoprotein levels and coronary heart disease. Biochemical findings indicate how lipoproteins interact and exert their physiological and pathophysiological effects. Lipids and lipoproteins, in general are discussed. The plasma cholesteral health consequences involve lipid distribution. Research, review and evolution of clinical trials of lipid lowering to prevent coronary heart disease are included. Specific topics include various aspects of hyperlipoproteinemia: classification, diagnosis, primary and secondary types, genetic characteristics, dietary and drug treatment, and surgical management.
Hyperlipidemia in Primary Care
Author: Matthew J. Sorrentino
Publisher: Springer Science & Business Media
ISBN: 9781603275026
Category : Medical
Languages : en
Pages : 300
Book Description
Cardiovascular disease is the number one cause of death for men and women in this country, surpassing deaths due to all cancers combined. Better awareness of heart disease risk factors and improved treatment modalities has produced great progress in reducing deaths due to myocardial infarction and stroke over the past few decades. Still, more progress is needed, as about half of all first coronary events occur in individuals who have no cardiac symptoms and no previously diagnosed heart disease. The primary care physician, therefore, has an important role in identifying at risk individuals and beginning preventive modalities. In Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction, a group of leading authorities in the field offers a comprehensive overview of the problem along with practical strategies for treating it. This unique title reviews methods for assessing risk in patients, including an important and thorough discussion of the Framingham algorithm and its limitations and advantages in assessing CVD risk. The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting these tests into proper perspective and offering a rational approach to using them in practice. Finally, treatment issues are covered. As treatment has expanded to more risk groups, a number of different guidelines have been published with recommended lipid goals. This is an evolving area of research with rapidly changing guidelines that are expanding the pool of high risk patients. An invaluable reference that offers a reasonable approach to risk assessment and treatment of individuals at increased cardiovascular risk, Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction provides the background needed to make scientifically based decisions that can ultimately help greatly reduce the number of patients impacted by cardiovascular disease.
Publisher: Springer Science & Business Media
ISBN: 9781603275026
Category : Medical
Languages : en
Pages : 300
Book Description
Cardiovascular disease is the number one cause of death for men and women in this country, surpassing deaths due to all cancers combined. Better awareness of heart disease risk factors and improved treatment modalities has produced great progress in reducing deaths due to myocardial infarction and stroke over the past few decades. Still, more progress is needed, as about half of all first coronary events occur in individuals who have no cardiac symptoms and no previously diagnosed heart disease. The primary care physician, therefore, has an important role in identifying at risk individuals and beginning preventive modalities. In Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction, a group of leading authorities in the field offers a comprehensive overview of the problem along with practical strategies for treating it. This unique title reviews methods for assessing risk in patients, including an important and thorough discussion of the Framingham algorithm and its limitations and advantages in assessing CVD risk. The book also reviews the evolving world of lipidology and how to apply many of the newer lipid tests to patients in daily practice, putting these tests into proper perspective and offering a rational approach to using them in practice. Finally, treatment issues are covered. As treatment has expanded to more risk groups, a number of different guidelines have been published with recommended lipid goals. This is an evolving area of research with rapidly changing guidelines that are expanding the pool of high risk patients. An invaluable reference that offers a reasonable approach to risk assessment and treatment of individuals at increased cardiovascular risk, Hyperlipidemia in Primary Care: A Practical Guide to Risk Reduction provides the background needed to make scientifically based decisions that can ultimately help greatly reduce the number of patients impacted by cardiovascular disease.
Statin-Associated Muscle Symptoms
Author: Paul D. Thompson
Publisher: Springer Nature
ISBN: 3030333043
Category : Medical
Languages : en
Pages : 191
Book Description
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
Publisher: Springer Nature
ISBN: 3030333043
Category : Medical
Languages : en
Pages : 191
Book Description
This book provides an overview of statin-associated muscle symptoms (SAMS) from clinical presentation to treatment and possible metabolic causes. It examines the risk factors, presentations, diagnosis and differential diagnosis, clinical management, and financial costs of SAMS. The book also highlights patients’ perspectives on SAMS such as the psychosocial, emotional, and societal factors influencing their perceptions and experiences. Finally, the book presents the results of observational and clinical trials on the prevalence of SAMS, clinical trials for treatments, and potential future research approaches for improving the understanding and treatment of SAMS. A key addition to the Contemporary Cardiology series, Statin-Associated Muscle Symptoms is an essential resource for physicians, medical students, residents, fellows, and allied health professionals in cardiology, endocrinology, pharmacotherapy, primary care, and health promotion and disease prevention.
Lipid Management
Author: Hussein Yassine
Publisher: Springer
ISBN: 3319111612
Category : Medical
Languages : en
Pages : 268
Book Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.
Publisher: Springer
ISBN: 3319111612
Category : Medical
Languages : en
Pages : 268
Book Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.
Drug Treatment of Hyperlipidemia
Author: B. Rifkind
Publisher: CRC Press
ISBN: 9780824785123
Category : Medical
Languages : en
Pages : 296
Book Description
Originally published in 1991, ' Drugs Treatment of Hyperlipidemia' is a collection of essays that include studies on lipid metabolism, diagnosis of lipoprotein disorders, detection and treatment of dyslipoporteinemia and trials of lipid lowering drugs amongst its topics
Publisher: CRC Press
ISBN: 9780824785123
Category : Medical
Languages : en
Pages : 296
Book Description
Originally published in 1991, ' Drugs Treatment of Hyperlipidemia' is a collection of essays that include studies on lipid metabolism, diagnosis of lipoprotein disorders, detection and treatment of dyslipoporteinemia and trials of lipid lowering drugs amongst its topics
Fact Sheet -- Hyperlipoproteinemia
Author: National Institutes of Health (U.S.)
Publisher:
ISBN:
Category : Hyperlipoproteinemia
Languages : en
Pages : 12
Book Description
Publisher:
ISBN:
Category : Hyperlipoproteinemia
Languages : en
Pages : 12
Book Description
Treatment of Hyperlipoproteinemia
Author: Lars A. Carlson
Publisher:
ISBN: 9780608003603
Category :
Languages : en
Pages : 304
Book Description
Publisher:
ISBN: 9780608003603
Category :
Languages : en
Pages : 304
Book Description
Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (adult Treatment Panel II).
Author: National Cholesterol Education Program (U.S.). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Publisher:
ISBN:
Category : Blood cholesterol
Languages : en
Pages : 184
Book Description
The panel examined the available evidence on coronary heart disease and high blood cholesterol and updated, where appropriate, the existing recommendations for management of high blood cholesterol in adults. Provides new recommendations for: patients with established coronary heart disease and others at high risk for coronary heart disease; HDL-cholesterol in coronary heart disease risk assessment; cholesterol lowering in women, the elderly, and young adults; physical activity and weight loss as components of dietary therapy; and delay of drug treatment in most young men and premenopausal women who are otherwise at low risk for coronary heart disease. Discusses cholesterol lowering and total mortality, and cost-effectiveness of cholesterol lowering.
Publisher:
ISBN:
Category : Blood cholesterol
Languages : en
Pages : 184
Book Description
The panel examined the available evidence on coronary heart disease and high blood cholesterol and updated, where appropriate, the existing recommendations for management of high blood cholesterol in adults. Provides new recommendations for: patients with established coronary heart disease and others at high risk for coronary heart disease; HDL-cholesterol in coronary heart disease risk assessment; cholesterol lowering in women, the elderly, and young adults; physical activity and weight loss as components of dietary therapy; and delay of drug treatment in most young men and premenopausal women who are otherwise at low risk for coronary heart disease. Discusses cholesterol lowering and total mortality, and cost-effectiveness of cholesterol lowering.